Strategies for prevention of cardiovascular disease in adults with hypertension
- PMID: 32003922
- PMCID: PMC8029987
- DOI: 10.1111/jch.13797
Strategies for prevention of cardiovascular disease in adults with hypertension
Keywords: antihypertensive treatment; blood pressure; cardiovascular disease; guidelines; hypertension.
Conflict of interest statement
None for Drs. Whelton, Lackland, Parati, Ram or Zhang. Dr Campbell was a paid consultant to the Novartis Foundation (2016‐2017) to support their program to improve hypertension control in low‐ to middle‐income countries which includes travel support for site visits and a contract to develop a survey, provided paid consultative advice on accurate BP assessment to Midway Corporation (2017), and is an unpaid member of World Action on Salt and Health (WASH). Dr Weber has received research/consultant fees from AbbVie and Bristol Myers Smith, and honoraria from ReCor Medical, Medtronic, Johnson & Johnson, Ablative Solutions, Boston Scientific, Omron, Sanofi, and Astellas.
Comment on
-
Is the concept of hypertension as a disease unhelpful?Lancet. 2019 Aug 24;394(10199):611. doi: 10.1016/S0140-6736(19)31964-6. Lancet. 2019. PMID: 31448722 No abstract available.
References
-
- The Lancet . Is the concept of hypertension as a disease unhelpful? Lancet. 2019;394(10199):611. - PubMed
-
- Geldsetzer P, Manne‐Goehler J, Marcus M‐E, et al. The state of hypertension care in 44 low‐income and middle‐income countries: a cross‐sectional study of nationally representative individual‐level data from 1.1 million adults. Lancet. 2019;394(10199):652‐662. - PubMed
-
- Forouzanfar MH, Liu P, Roth GA, et al. Global burden of hypertension and systolic blood pressure of at least 110 to 115 mm Hg, 1990–2015. JAMA. 2017;317(2):165‐182. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical